Home / Alternatives to EXPAREL® NOW Apps Like EXPAREL® NOW for iPhone and iPad
by Pacira Pharmaceuticals, Inc. ★ 5.0 1 ratings Medical Free Data updated 2026-09-06
Ranked alternatives Showing 661–680 of 1,000 ranked alternatives.
MINDSCLIK DIGITAL SOLUTIONS PRIVATE LIMITED
★ 0.0 0 ratings Business Free Data updated 2026-09-06
Jean-Charles LE HUEC
★ 3.0 2 ratings Medical $9.99 Data updated 2026-09-09
COMPLIANCE MEDS TECHNOLOGIES, LLC
★ 3.0 2 ratings Medical Free Data updated 2026-09-12
OSMAN SERDAR SARITAS
★ 5.0 1 ratings Medical Free Data updated 2026-09-06
Visual Net Design, LC
★ 1.0 1 ratings Utilities Free Data updated 2026-09-06
dana Portenier
★ 0.0 0 ratings Medical $1.99 Data updated 2026-09-06
U.S. Anesthesia Partners Intermediate Holdings II, Inc.
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
立剑 岑
★ 0.0 0 ratings Medical Free Data updated 2026-09-14
Ahmad Al Hariri
★ 0.0 0 ratings Medical $69.99 Data updated 2026-09-06
InSimo
★ 1.0 1 ratings Medical Free Data updated 2026-10-17
ZIOS Corporation
★ 5.0 1 ratings Reference Free Data updated 2026-09-10
ThinkSono GmbH
★ 5.0 2 ratings Medical Free Data updated 2026-09-06
Optimed Limited
★ 0.0 0 ratings Medical Free Data updated 2026-09-10
Suhaib Harraka
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
david flikier
★ 0.0 0 ratings Medical Free Data updated 2026-09-11
Darya Pyzhyk
★ 5.0 1 ratings Education Free Data updated 2026-09-06
Portable Databases
Antibiotic susceptibility patterns on mobile.
The app provides local susceptibility patterns for antibiotic selection. Users select a bacterium and patient group to view antibiotic susceptibility proportions for their local laboratory.
★ 1.0 1 ratings Medical Free Data updated 2026-10-10
Ahmad Al Hariri
★ 0.0 0 ratings Medical $9.99 Data updated 2026-09-06
Piedmont Healthcare, Inc.
★ 5.0 1 ratings Medical Free Data updated 2026-09-08
Darya Pyzhyk
★ 0.0 0 ratings Education Free Data updated 2026-09-06
How we rank alternatives Apps are ranked by functional similarity, category fit, rating confidence, and popularity.
Previous Next